Cargando…
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
The combat against the Corona virus disease of 2019 (COVID-19), has created a chaos among the healthcare institutions and researchers, in turn accelerating the dire need to curtail the infection spread. The already established entry mechanism, via ACE2 has not yet successfully aided in the developme...
Autores principales: | Behl, Tapan, Kaur, Ishnoor, Aleya, Lotfi, Sehgal, Aayush, Singh, Sukhbir, Sharma, Neelam, Bhatia, Saurabh, Al-Harrasi, Ahmed, Bungau, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634688/ https://www.ncbi.nlm.nih.gov/pubmed/34863742 http://dx.doi.org/10.1016/j.scitotenv.2021.152072 |
Ejemplares similares
-
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
por: Sharma, Neelam, et al.
Publicado: (2022) -
There is nothing exempt from the peril of mutation – The Omicron spike
por: Behl, Tapan, et al.
Publicado: (2022) -
A motley of possible therapies of the COVID-19: reminiscing the origin of the pandemic
por: Kaur, Ishnoor, et al.
Publicado: (2022) -
Targeting Endothelin in Alzheimer's Disease: A Promising Therapeutic Approach
por: Sharma, Shiwali, et al.
Publicado: (2021) -
Targeting natural products against SARS-CoV-2
por: Al-Harrasi, Ahmed, et al.
Publicado: (2022)